Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis

Osteoporosis epidemiology 2013

(2014) William D. Leslie et al.   CURRENT OPINION IN RHEUMATOLOGY

Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults

(2014) Bradley C. Johnston et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinician’s Guide to Prevention and Treatment of Osteoporosis

(2014) F. Cosman et al.   OSTEOPOROSIS INTERNATIONAL

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

(2013) Nelson Watts et al.   Endocrine Practice

Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis

(2013) Ana Julissa Serrano et al.   GYNECOLOGICAL ENDOCRINOLOGY

Temporal Trends in Obesity, Osteoporosis Treatment, Bone Mineral Density, and Fracture Rates: A Population-Based Historical Cohort Study

(2013) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men

(2013) J.-M. Kaufman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Death, Debility, and Destitution Following Hip Fracture

(2013) Gabriel S. Tajeu et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study

(2012) Steven Boonen et al.   BONE

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

(2012) Steven Boonen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis

(2012) N. Freemantle et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Changes in femur neck bone density in US adults between 1988–1994 and 2005–2008: demographic patterns and possible determinants

(2011) A. C. Looker et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy and safety of monthly ibandronate in men with low bone density

(2010) Eric S. Orwoll et al.   BONE

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

(2010) Eric S Orwoll et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

(2010) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The effects of weekly alendronate therapy in Taiwanese males with osteoporosis

(2009) Jawl-Shan Hwang et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Efficacy of Risedronate in Japanese Male Patients with Primary Osteoporosis

(2008) Takafumi Majima et al.   INTERNAL MEDICINE

Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study

(2008) Steven Boonen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Use of Indirect and Mixed Treatment Comparisons for Technology Assessment

(2008) Alex Sutton et al.   PHARMACOECONOMICS

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

(2008) Johann D. Ringe et al.   RHEUMATOLOGY INTERNATIONAL